Timolol/pilocarpine combination eye drops in open angle glaucoma and in ocular hypertension. A controlled randomized study

Acta Ophthalmologica
G Høvding, H Aasved

Abstract

The effect of a newly developed ophthalmic solution containing both 0.5% timolol and 2% resp. 4% pilocarpine was compared with that of timolol 0.5% eye drops alone in 93 patients with manifest simple or capsular glaucoma or ocular hypertension. The medications were administered twice daily. The absolute additive effect of pilocarpine was small, although the combined solutions caused a statistically significantly greater reduction of the intraocular pressure than that achieved by timolol alone. This additional effect appeared to last at least 12 h. The effect of the test solutions containing 2% resp. 4% pilocarpine was very similar. Apart from the well-known effects of the pilocarpine-induced miosis, the combined test medications were generally well tolerated.

References

Oct 1, 1978·Acta Ophthalmologica·E Kerty, I Hørven
Jul 2, 1979·Albrecht Von Graefes Archiv Für Klinische Und Experimentelle Ophthalmologie. Albrecht Von Graefe's Archive for Clinical and Experimental Ophthalmology·M Ober, A Scharrer
Apr 1, 1977·Archives of Ophthalmology·T J Zimmerman, H E Kaufman
Nov 1, 1978·Archives of Ophthalmology·R L Coakes, R F Brubaker
Sep 1, 1979·American Journal of Ophthalmology·E U Keates
Aug 1, 1979·Acta Ophthalmologica·H AasvedJ E Slagsvold
Jan 1, 1979·Acta Ophthalmologica·N V Nielsen, J S Eriksen
Nov 1, 1977·The British Journal of Ophthalmology·R DavidM H Luntz
Sep 1, 1970·Journal of Pharmaceutical Sciences·P H ChungJ L Lach
Nov 1, 1970·Archives of Ophthalmology·L S Harris, M A Galin
Mar 1, 1982·Ophthalmology·W M Hart, B Becker
Sep 1, 1982·Ophthalmology·W M Grant, J F Burke
Mar 1, 1980·Archives of Ophthalmology·I Hass, S M Drance
Nov 1, 1981·American Journal of Ophthalmology·S E Norell
Jan 1, 1964·American Journal of Ophthalmology·A E KRILL, F W NEWELL

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.